1995
DOI: 10.1016/0300-483x(95)03056-l
|View full text |Cite
|
Sign up to set email alerts
|

Lymphotoxicity and myelotoxicity of doxorubicin and SDZ PSC 833 combined chemotherapies for normal mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

1998
1998
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(4 citation statements)
references
References 14 publications
0
4
0
Order By: Relevance
“…This scenario can be explained by other studies showing that Dox treatment led to the depletion of lymphocytes in peripheral lymphoid organs (Pourtier-Manzanedo et al. 1995 ), lymphocyte stem cells dysfunction and mature lymphocyte destruction (Steele 2002 ). Importantly, the role of antioxidants has been reported in restoring these complications (Merzoug et al.…”
Section: Discussionmentioning
confidence: 89%
“…This scenario can be explained by other studies showing that Dox treatment led to the depletion of lymphocytes in peripheral lymphoid organs (Pourtier-Manzanedo et al. 1995 ), lymphocyte stem cells dysfunction and mature lymphocyte destruction (Steele 2002 ). Importantly, the role of antioxidants has been reported in restoring these complications (Merzoug et al.…”
Section: Discussionmentioning
confidence: 89%
“…Its therapeutic potential is realized through various pathways, including DNA intercalation, DNA topoisomerase II inhibition, and induction of the oxidative stress in target cells (3). Numerous data indicate that Dx-mediated ROS production is the leading reason of an acute myelotoxicity and nephrotoxicity of this drug (4,5). However, the most dangerous consequence of Dx-induced oxidative stress is a delayed cardiac failure found in 18% cancer patients who received more than 551 mg/m 2 dose of this drug (6).…”
mentioning
confidence: 99%
“…While, doxorubicinassociated granulocytopenia and monocytopenia might be a result of pronounced marrow depression caused by administration of doxorubicin (Falkson et al, 1985;Tsang et al, 2007). On the other hand, doxorubicin-induced lymphopenia could be explained based on the ability of doxorubicin to destroy the population of mature lymphocyte and elimination its precursors (Steele, 2002), depleting lymphocyte number in peripheral blood stream, thymus, spleen and lymph nodes (Pourtier-Manzanedo et al, 1995). The resultant leucopenia and lymphopenia upon treatment with doxorubicin was previously reported by Merzoug et al (2014); Ja´cevi´c et al (2018).…”
Section: Discussionmentioning
confidence: 99%